When should stress ulcer prophylaxis be used in the ICU?

Current Opinion in Critical Care

Volumn 15, Issue 2, 2009, Pages 139-143

  Quenot, Jean Pierre ^a,b   Thiery, Nadiejda ^a   Barbar, Saber ^a  

^a DIJON UNIVERSITY HOSPITAL   (France)

^b HÔPITAL DU BOCAGE   (France)

Author keywords

ICU; Prophylaxis; Stress ulcer

Indexed keywords

ANTACID AGENT; CIMETIDINE; CIPROFLOXACIN; CORTICOSTEROID; DIGOXIN; HISTAMINE AGONIST; HYDROCORTISONE; KETOCONAZOLE; LEVOTHYROXINE; OMEPRAZOLE; PHENYTOIN; PROTON PUMP INHIBITOR; RANITIDINE; STEROID; SUCRALFATE; THEOPHYLLINE; WARFARIN;

ABDOMINAL PAIN; ACUTE KIDNEY FAILURE; ACUTE LUNG INJURY; ALUMINUM OVERLOAD; ANTICOAGULATION; BLOOD CLOTTING DISORDER; CLINICAL TRIAL; CONFUSION; CONSTIPATION; CRITICALLY ILL PATIENT; DELIRIUM; DIARRHEA; DRUG ABSORPTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG METABOLISM; ENTERIC FEEDING; EVALUATION; EVIDENCE BASED MEDICINE; GASTROINTESTINAL HEMORRHAGE; HALLUCINATION; HEAD INJURY; HEALTH CARE PERSONNEL; HUMAN; INFECTIOUS DIARRHEA; INTENSIVE CARE UNIT; LIVER FAILURE; MAJOR SURGERY; NASOGASTRIC TUBE; NAUSEA; PHYSICIAN; PROPHYLAXIS; RESPIRATORY FAILURE; REVIEW; RISK FACTOR; SEPSIS; SLURRED SPEECH; SPINAL CORD INJURY; STOMACH ACID SECRETION; STOMACH HEMORRHAGE; STOMACH PH; STOMACH PROTECTION; STRESS ULCER; THERMAL INJURY; THROMBOCYTOPENIA; UNSPECIFIED SIDE EFFECT;

ANTI-ULCER AGENTS; ENTERAL NUTRITION; HISTAMINE H2 ANTAGONISTS; HUMANS; INTENSIVE CARE UNITS; PEPTIC ULCER; PROTON PUMP INHIBITORS; RECEPTORS, HISTAMINE; RISK FACTORS; STRESS, PHYSIOLOGICAL; SUCRALFATE;

EID: 67749093219     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0b013e32832978e0     Document Type: Review

References (50)

1. Cook DJ, Reeve BK, Guyatt GH, et al. Stress ulcer prophylaxis in critically ill patients: resolving discordant meta-analyses. JAMA 1996; 275:308-314.
2. American Society of Health-System Pharmacists Commission on Therapeutics. ASHP therapeutic guidelines on stress ulcer prophylaxis. Am J Health Syst Pharm 1999; 56:347-379.
3. Daley RJ, Rebuck JA, Welage LS, et al. Prevention of stress ulceration: current trends in critical care. Crit Care Med 2004; 32:2008-2013.
4. Lam NP, Lee PT, Crawford SY, et al. National survey of stress ulcer prophylaxis. Crit Care Med 1999; 27:98-103.
5. Quenot JP, Mentec H, Feihl F, et al. Bedside adherence to clinical practice guidelines in the intensive care unit: the TECLA study. Intensive Care Med 2008; 34:1293-1400. An observational, multicenter, European study concerning actual bedside adherence to clinical practice guidelines for stress-ulcer prophylaxis.
6. Tryba M, Cook D. Current guidelines on stress ulcer prophylaxis. Drugs 1997; 54:581-596.
7. Marrone GC, Silen W. Pathogenesis, diagnosis and treatment of acute gastric mucosal lesions. Clin Gastroenterol 1984; 13:635-650.
8. Beejay U, Wolfe MM. Acute gastrointestinal bleeding in the intensive care unit. The gastroenterologist's perspective. Gastroenterol Clin North Am 2000; 29:309-336.
9. Cook D, Guyatt G, Marshall J, et al. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. N Engl J Med 1998; 338:791-797.
10. Schuster DP, Rowley H, Feinstein S, et al. Prospective evaluation of the risk of upper gastrointestinal bleeding after admission to a medical intensive care unit. Am J Med 1984; 76:623-630.
11. Fabian TC, Bouchez BA, Croce MA, et al. Pneumonia and stress ulceration in severely injured patients. A prospective evaluation of the effects of stress ulcer prophylaxis. Arch Surg 1993; 12:185-191.
12. Cook DJ, Griffith LE, Walter SD, et al. The attributable mortality and length of intensive care unit stay of clinically important gastrointestinal bleeding in critically ill patients. Crit Care 2001; 5:368-375.
13. Martindale RG. Contemporary strategies for the prevention of stress-related mucosal bleeding. Am J Health Syst Pharm 2005; 62 (10 Suppl 2):S11-S17.
14. Fennerty MB. Pathophysiology of the upper gastrointestinal tract in the critically ill patient: rational for the therapeutic benefits of acid suppression. Crit Care Med 2002; 30 (6 Suppl):S351-S355.
15. Mutlu GM, Mutlu EA, Factor P. GI complications in patients receiving mechanical ventilation. Chest 2001; 119:1222-1241.
16. Cook DJ, Fuller HD, Guyatt GH, et al. Risk factors for gastrointestinal bleeding in critically ill patients. N Engl J Med 1994; 330:377-381.
17. Cook D, Heyland D, Griffith L, et al. Risk factors for clinically important upper gastrointestinal bleeding in patients requiring mechanical ventilation. Crit Care Med 1999; 27:2812-2817.
18. Tryba M. Role of acid suppressants in intensive care medicine. Best Pract Res Clin Gastroenterol 2001; 15:447-461.
19. Martin LF, Booth FV, Reines HD, et al. Stress ulcer and organ failure in intubated patients in surgical intensive care units. Ann Surg 1992; 215:332-337.
20. Schuster DP. Stress ulcer prophylaxis: in whom? With what? Crit Care Med 1993; 21:4-6.
21. Messori A, Trippoli S, Gorini M, Corrado A. Bleeding and pneumoniae in intensive care patients given ranitidine and sucralfate for prevention of stress ulcer: meta-analysis of randomised controlled trials. BMJ 2000; 321:1103-1106.
22. Spirt MJ, Stanley S. Update on stress ulcer prophylaxis in critically ill patients. Crit Care Nurses 2006; 26:18-29.
23. MacLaren R, Jarvis CL, Fish DN. Use of enteral nutrition for stress ulcer prophylaxis. Ann Pharmacother 2001; 35:1614-1623.
24. Raynard B, Bernard B, Bleichner G, et al. [Prevention of upper digestive stress hemorrhage in critical care. Revision of the 1988 Consensus Conference]. Réanim Urgences 2000; 9:555-600.
25. Kahn JM, Doctor JN, Rubenfeld GD. Stress ulcer prophylaxis in mechanically ventilated patients: integrating evidence and judgment using a decision analysis. Intensive Care Med 2006; 32:1151-1158.
26. [Anti-ulcer agents: indications in adult patients. Recommendations for good practice. French Agency for the Sanitary Safety of Health Products]. Gastroenterol Clin Biol 2000; 24:447-460.
27. Stollman N, Metz DC. Pathophysiology and prophylaxis of stress ulcer in intensive care unit patients. J Crit Care 2005; 20:35-45.
28. Pimental M, Roberts DE, Bernstein CN, et al. Clinically significant gastrointestinal bleeding in critically ill patients in an era of prophylaxis. Am J Gastroenterol 2000; 95:2801-2806.
29. Kantorova I, Svoboda P, Scheer P, et al. Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial. Hepatogastroenterology 2004; 51:757-761.
30. Faisy C, Guerot E, Diehl J, et al. Clinically significant gastrointestinal bleeding in critically ill patients with and without stress-ulcer prophylaxis. Intensive Care Med 2003; 29:1306-1313.
31. Cook DJ, Reeve BK, Guyatt GH, et al. Stress ulcer prophylaxis in the critically ill: a meta-analysis. Am J Med 1991; 91:519-527.
32. Geus WP. Are there indications for intravenous acid-inhibition in the prevention of upper GI bleeding? Scand J Gastroenterol Suppl 2000; 30:254-256.
33. Welage LS. Overview of pharmacologic agents for acid suppression in critically ill patients. Am J Health Syst Pharm 2005; 62 (10 Suppl 2):S4-S10.
34. Spirt MJ. Stress-related mucosal disease. Curr Treat Options Gastroenterol 2003; 6:135-145.
35. Spirt MJ. Stress-related mucosal disease: risk factors and prophylactic therapy. Clin Ther 2004; 26:197-213.
36. Mulla H, Peek G, Upton D, et al. Plasma aluminium levels during sucralfate prophylaxis for stress ulceration in critically ill patients on continuous venovenous hemofiltration: a randomised, controlled trial. Crit Care Med 2001; 29:267-271.
37. Prod'hom G, Leuenberger P, Koerfer J, et al. Nosocomial pneumonia in mechanically ventilated patients receiving antacid, ranitidin, or sucralfate as prophylaxis for stress ulcer. Ann Intern Med 1994; 120:6653-6662.
38. Safdar N, Crnich C, Maki DG. The pathogenesis of ventilator-associated pneumonia: its relevance to developing effective strategies for prevention. Respir Care 2005; 50:725-739.
39. Tryba M. The gastropulmonary route of infection: fact or fiction? Am J Med 1991; 91 (Suppl 2A):135S-146S.
40. Apte NM, Karnad DR, Medhekar TP, et al. Gastric colonization and pneumonia in intubated critically ill patients receiving stress ulcer prophylaxis: a randomized, controlled trial. Crit Care Med 1992; 20:590-593.
41. Driks MR, Craven DE, Celli BR, et al. Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers. The role of gastric colonization. N Engl J Med 1987; 317:1376-1382.
42. Ben-Menachem T, Fogel R, Patel RV, et al. Prophylaxis for stress-related gastric hemorrhage in the medical intensive care unit. Ann Int Med 1994; 121:568-575.
43. Martin LF, Booth FVM, Karlstadt RG, et al. Continuous intravenous cimetidine decrease stress-related gastrointestinal hemorrahge without promoting pneumonia. Crit Care Med 1993; 21:19-30.
44. Tryba M. Sucralfate versus antacids or H2-antagonists for stress ulcer prophylaxis. A meta-analysis on efficacy and pneumonia rate. Crit Care Med 1991; 19:942-949.
45. Harty RF, Ancha HB. Stress ulcer bleeding. Curr Treat Options Gastroenterol 2006; 9:157-166.
46. Lasky MR, Metzler MH, Philipps JO. A prospective study of omeprazole suspension to prevent clinically significant gastrointestinal bleeding from ulcers in mechanically ventilated trauma patients. J Trauma 1998; 44:527-533.
47. Conrad SA, Gabrielli A, Margolis B, et al. Randomized, double-blind comparison of immediate-release omeprazole suspension versus intravenous cimetidine for the prevention of upper gastrointestinal bleeding in critically ill patients. Crit Care Med 2005; 33:760-765.
48. Jung R, MacLaren R. Proton-pump inhibitors in acute stress ulcer prophylaxis in critically ill patients. Ann Pharmacother 2002; 36:1929-1937.
49. Dial S, Alrasadi K, Manoukian C, et al. Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies. CMAJ 2004; 171:33-38.
50. Levy M, Seelig CB, Robinson NJ, et al. Comparison of omeprazole and ranitidine for stress ulcer prophylaxis. Gig Dis Sci 1997; 42:1255-1259.